kenacort 40 mg/ ml
orifarm as - triamcinolonacetonid - injeksjonsvæske, suspensjon - 40 mg/ ml
kenacort-t 40 mg/ ml
bristol-myers squibb ab - triamcinolonacetonid - injeksjonsvæske, suspensjon - 40 mg/ ml
kenacort-t 40 mg/ ml
2care4 aps - triamcinolonacetonid - injeksjonsvæske, suspensjon - 40 mg/ ml
methylprednisolone orion 4 mg
orion corporation orion pharma, espoo - metylprednisolon - tablett - 4 mg
methylprednisolone orion 16 mg
orion corporation orion pharma, espoo - metylprednisolon - tablett - 16 mg
sogroya
novo nordisk a/s - somapacitan - vekst - hypofysiske og hypotalamiske hormoner og analoger - sogroya is indicated for the replacement of endogenous growth hormone (gh) in children aged 3 years and above, and adolescents with growth failure due to growth hormone deficiency (paediatric ghd), and in adults with growth hormone deficiency (adult ghd).